Zimmer Biomet Holdings, Inc. (ZBH)
Market Cap | 21.32B |
Revenue (ttm) | 7.60B |
Net Income (ttm) | 1.08B |
Shares Out | 199.04M |
EPS (ttm) | 5.26 |
PE Ratio | 20.38 |
Forward PE | 12.69 |
Dividend | $0.96 (0.90%) |
Ex-Dividend Date | Sep 30, 2024 |
Volume | 3,969,105 |
Open | 105.34 |
Previous Close | 105.81 |
Day's Range | 105.34 - 107.76 |
52-Week Range | 101.47 - 133.90 |
Beta | 1.02 |
Analysts | Hold |
Price Target | 123.68 (+15.46%) |
Earnings Date | Feb 6, 2025 |
About ZBH
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open hear... [Read more]
Financial Performance
In 2023, Zimmer Biomet Holdings's revenue was $7.39 billion, an increase of 6.55% compared to the previous year's $6.94 billion. Earnings were $1.02 billion, an increase of 342.52%.
Financial StatementsAnalyst Forecast
According to 21 analysts, the average rating for ZBH stock is "Hold." The 12-month stock price forecast is $123.68, which is an increase of 15.46% from the latest price.
News
Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthcare Conference
WARSAW, Ind. , Dec. 20, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will be presenting at the 43rd Annual J....
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024
WARSAW, Ind. , Dec. 18, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment ...
Zimmer Biomet Receives FDA Clearance for OsseoFit™ Stemless Shoulder System for Total Shoulder Replacement
New Anatomically Shaped Asymmetric Stemless Design for Total Shoulder Replacement WARSAW, Ind., Dec. 13, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technol...
Zimmer Biomet Receives FDA Clearance for Persona® SoluTion™ PPS® Femur
A Total Knee Replacement Alternative for Patients with Metal and/or Bone Cement Sensitivities WARSAW, Ind., Dec. 4, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medi...
Zimmer Biomet Receives FDA Approval for Oxford® Cementless Partial Knee, Only Cementless Partial Knee Replacement Implant in the U.S.
WARSAW, Ind., Nov. 25, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) Premarket Appr...
Zimmer Biomet to Present at Citi's 2024 Global Healthcare Conference
WARSAW, Ind. , Nov. 21, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will participate in the Citi Global Heal...
Zimmer Biomet Announces CE Mark Certification for Persona® Revision Knee System
WARSAW, Ind., and ZURICH , Nov. 18, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE: ZBH and SIX: ZBH), a global medical technology leader, today received the CE Mark for its Persona® Revision...
Arnold Schwarzenegger partners with Zimmer Biomet as chief movement officer
Arnold Schwarzenegger, former governor of California, and Ivan Tornos, president and CEO of Zimmer Biomet, join CNBC's 'Power Lunch' to discuss their partnership in promoting orthopedic health, how Zi...
Zimmer Biomet Welcomes Arnold Schwarzenegger as Chief Movement Officer
Schwarzenegger to Inspire a Bold New Era of Well-being, Active Living and Reinvention to Advance Company's Mission to Alleviate Pain and Improve the Quality of Life for People Around the World WARSAW,...
Zimmer Biomet to Present at Jefferies London Healthcare Conference
WARSAW, Ind. , Nov. 7, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will participate in the Jefferies London ...
Orthopedic Implant Maker Zimmer Biomet Reports Better-Than-Expected Q3 Earnings, Updates Annual Forecasts
On Wednesday, Zimmer Biomet Holdings, Inc ZBH reported third-quarter adjusted EPS of $1.74, up from $1.65 a year ago, in line with the Street estimates.
Zimmer Biomet Holdings, Inc. (ZBH) Q3 2024 Earnings Call Transcript
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q3 2024 Earnings Conference Call October 30, 2024 8:30 AM ET Company Participants David DeMartino – Senior Vice President-Investor Relations Ivan Tornos – Pres...
Implant maker Zimmer Biomet lowers full-year profit forecast
Hip implant maker Zimmer Biomet lowered its annual profit forecast on Wednesday following last month's disruptions to a software platform that was managing some of the company's operations.
Zimmer Biomet Announces Third Quarter 2024 Financial Results
Third quarter net sales of $1.824 billion increased 4.0% and 4.1% on a constant currency1 basis Third quarter diluted earnings per share were $1.23; adjusted1 diluted earnings per share were $1.74 Com...
Zimmer Biomet to Debut New Z1™ Femoral Hip System and Clinical Data on G7® Acetabular System at 2024 AAHKS Annual Meeting
Company's Booth Spotlights Comprehensive Hip Portfolio and Enabling Technologies Including OrthoGrid Hip AI® and HAMMR™ Automated Hip Impaction System WARSAW, Ind. , Oct. 28, 2024 /PRNewswire/ -- Zimm...
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2024 Financial Results
WARSAW, Ind. , Oct. 9, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its third quarter earnings conference call will be webcast on Wednesday, October 30, 2024 a...
Large Joint Devices Market Size, Share, and Global Trends Analysis 2024-2030: Zimmer Biomet Leads Global Hip Reconstruction Market with Taperloc and Arcos Systems
Dublin, Oct. 07, 2024 (GLOBE NEWSWIRE) -- The "Large Joint Devices Market Size, Share, and Trends Analysis Global 2024-2030 MedSuite Includes: Knee Replacement Market, Hip Replacement Market, and 1 mo...
Zimmer Biomet: The Undervalued Titan Of Joint Replacements
Zimmer Biomet, a leader in musculoskeletal health, excels in knee and hip replacements, and surgical robots, making it a sticky choice for many orthopedic surgeons. Competitive advantages include stro...
Zimmer Biomet Stock Falls After the Medtech Firm Warns of Software Switch Impact
Shares of Zimmer Biomet Holdings (ZBH) dropped nearly 9% after the manufacturer of artificial joint replacements and other orthopedic products warned the implementation of a new enterprise resources p...
Zimmer Biomet Names David DeMartino as Senior Vice President, Investor Relations
WARSAW, Ind. , Sept. 5, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that David DeMartino will join the Company as Senior ...
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2024
WARSAW, Ind. , Aug. 29, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment ...
Zimmer Biomet to Present at the Wells Fargo 2024 and Morgan Stanley Annual Global Healthcare Conferences
WARSAW, Ind. , Aug. 21, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team wil...
Zimmer Biomet beats profit estimates on strong demand for medical devices
Zimmer Biomet Holdings beat Wall Street estimates for second-quarter profit on Wednesday, driven by robust demand for its devices used in joint reconstruction procedures.
Zimmer Biomet Signs Definitive Agreement to Acquire OrthoGrid Systems, Inc.
Acquisition Expands Hip Portfolio with Artificial Intelligence-Driven Surgical Guidance System WARSAW, Ind., Aug. 7, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global med...
10 Beaten-Up Blue Chips With Serious Turnaround Potential
Here is my list of blue-chip stocks to research for a buy-on-weakness strategy. Each has the potential to dip by -10% to -20%, given the July S&P 500 correction expands into a more serious bear market...